Róbert Babeľa is a specialist in the field of health technology assessment, which he has been working on for more than a decade. He is a graduate of three universities including the Open University Business School, London, UK and the University of Sheffield, Sheffield, UK. He is the author and co-author of more than 180 publications at home and abroad, and has gained practical skills during his more than 20 years in various positions in the healthcare sector, where he continues to work. Prof. PhDr. Róbert Babeľa, PhD., MBA, MSc (HTA), FISAC is a member of several editorial boards of international journals and professional companies. He currently focuses on scientific projects related to the quantification of the actual total costs of sel…

Ján Kyselovič graduated from the Faculty of Pharmacy of the Charles University in 1987. He finished his studies with the Rector's Award. He completed his postgraduate studies in the field of Pharmacology at the Faculty of Medicine of the Charles University in 1993. Subsequently, between 1992 and 2004, he participated in 4 long-term scientific and research stays abroad in Canada and Belgium. In 2005-2010, he was the head of the Department of Pharmacology and Toxicology at the Faculty of Pharmacy. Since 2009, he has been a full professor in the field of "Pharmacology", guarantor of the master's study program in Pharmacy, doctoral studies in the field of Pharmacology. In the years 2009-2013, he worked in the position of dean of the faculty.…

Top management of people and companies has been part of his professional life for more than 20 years. He headed the teams of international companies at ING Nationale Nederlanden, the insurance company Allianz or the insurance company Aegon. He is currently devoting all his experience in the field of financial services and insurance to the largest health insurance company in Slovakia, VšZP. Together with his team, he transforms the insurance company into a modern company that sets trends on the public health insurance market. It works to make VšZP a synonym for affordable and high-quality healthcare, innovative treatment procedures, the latest technologies and humanity.

Norbert Žilka is currently the director of the Institute of Neuroimmunology of the SAS, where he held several research positions from 1998 to 2020. He specializes in research in the field of neurodegenerative diseases of the human brain and the preclinical and clinical development of drugs that modify this disease.

Jakub Fejfar graduated from the Faculty of Medicine of Charles University in Hradec Králové. He worked in hospitals in Valašský Meziříčí, in Nové Jičín and in the Central Military Hospital in Prague. Since 2012, he has been working in various positions at AGEL Hospital Nový Jičín a.s., currently as chairman of the board. In the AGEL Group, he is the guarantor for electronicization and telemedicine. He is also an external auditor and consultant of SAK.